Hong Kong
· Delayed Price · Currency is HKD Concord Healthcare Group Statistics
Total Valuation
Concord Healthcare Group has a market cap or net worth of HKD 19.20 billion. The enterprise value is 22.23 billion.
| Market Cap | 19.20B |
| Enterprise Value | 22.23B |
Important Dates
The next estimated earnings date is Friday, November 29, 2024.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Concord Healthcare Group has 716.34 million shares outstanding. The number of shares has increased by 2.80% in one year.
| Shares Outstanding | 716.34M |
| Shares Change (YoY) | +2.80% |
| Shares Change (QoQ) | +9.52% |
| Owned by Insiders (%) | 4.95% |
| Owned by Institutions (%) | 0.93% |
| Float | 114.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.74 |
| PB Ratio | 9.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -57.35 |
| EV / Sales | 43.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of 133.80.
| Current Ratio | 0.53 |
| Quick Ratio | 0.30 |
| Debt / Equity | 133.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.87 |
Financial Efficiency
Return on equity (ROE) is -19.54% and return on invested capital (ROIC) is -3.82%.
| Return on Equity (ROE) | -19.54% |
| Return on Assets (ROA) | -3.41% |
| Return on Capital (ROIC) | -3.82% |
| Revenue Per Employee | 734,668 |
| Profits Per Employee | -560,869 |
| Employee Count | 733 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 13.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 38.58 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 33.58 |
| Average Volume (20 Days) | 173,090 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Concord Healthcare Group had revenue of HKD 507.66 million and -387.56 million in losses. Loss per share was -0.56.
| Revenue | 507.66M |
| Gross Profit | -69.41M |
| Operating Income | -329.52M |
| Pretax Income | -449.92M |
| Net Income | -387.56M |
| EBITDA | -205.99M |
| EBIT | -329.52M |
| Loss Per Share | -0.56 |
Balance Sheet
The company has 342.44 million in cash and 3.10 billion in debt, giving a net cash position of -2.76 billion or -3.85 per share.
| Cash & Cash Equivalents | 342.44M |
| Total Debt | 3.10B |
| Net Cash | -2.76B |
| Net Cash Per Share | -3.85 |
| Equity (Book Value) | 2.32B |
| Book Value Per Share | 2.86 |
| Working Capital | -654.39M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -13.67%, with operating and profit margins of -64.91% and -76.34%.
| Gross Margin | -13.67% |
| Operating Margin | -64.91% |
| Pretax Margin | -88.63% |
| Profit Margin | -76.34% |
| EBITDA Margin | -40.58% |
| EBIT Margin | -64.91% |
| FCF Margin | n/a |
Dividends & Yields
Concord Healthcare Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.80% |
| Shareholder Yield | -2.80% |
| Earnings Yield | -2.08% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |